Nano Therapy Market – Global Industry Analysis and Forecast (2022-2029)


Nano Therapy Market size is expected to grow at a CAGR of 8.6% during the forecast period and the market size is expected to reach nearly US$ 342.02 Bn. by 2029.

Nano Therapy Market Dynamics

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanotherapy is a branch of Nano medicine that includes using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process called as targeting.

This report provides insights into the factors that are driving and restraining the global Nano Therapy market. Nanotherapy is also referred to as targeted therapy, which offers to transport the molecules to the affected cells to treat the disease without affecting other negative effects on the healthy cells. Nanoparticles allow for multiple functional groups to be added to the surface. Each of the functional groups contributes to the effectiveness of this method of therapy and deliver its components in a controlled way once it gets to the target cells/tissue. Nano therapy is considered as recent technology for some diseases, which are implemented with the help of submicron-sized molecular devices or nanoparticles. Nanoparticles can improve the drug accessibility in the body with strength, drag out the medication, and can upsurge the half-life of plasma and boost the drug specificity. These are the factors driving the growth of the Nano therapy market.

Global Nano Therapy Market
To know about the Research Methodology :- Request Free Sample Report

As compared to the conventional methods, this method has increased more popularity owing to its high accuracy when it comes to administering therapeutic formulations. The market is thriving, with around 250 Nano-medical products being verified or used for humans. Though, with Nano therapy, the carrier is protected from degradations, which allows it to reach given target cells in the body for a local reaction. Nano therapy is considerably used in the treatment of diseases like cancer, diabetes, and cardiovascular diseases. A recent study by the Journal of Diabetes and Metabolic diseases has stated that the incidence of MS ranged from 30.5 to 31.5% in China and 35.8 to 45.3% in India.

However, an absence of controlling standards in the examination of Nano therapy and high expenditure of treatment are several of the major factors that are restraining the growth of the Nano therapy market during the forecast period.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nano Therapy Market Segment Analysis

Based on Type, the Nanomaterial segment is anticipated to grow at a CAGR of 20.8% during the forecast period. The nanomaterial is the materials with at least one exterior dimension in the size range of nearly 1 to 100 nanometers. The nanomaterial is intended for developing novel characteristics and has the potential to improve quality of life. The nanomaterial is generally used in cosmetics, healthcare, electronics, and other areas currently. Unceasing development and innovation in the field are impelling the growth of the global nanomaterials market. The amazing chemical and physical properties of materials at the nanometer scale allow novel applications. For instance, energy conservation and structural strength improvement to antimicrobial properties and self-cleaning surfaces. Nanotechnology is being increasingly efficient by spending mainly on R&D activities which are resulting in the development of current technologies and innovations with reference to the new materials.

Nano Therapy Market Regional Insights

North America region dominated the Nano therapy market with US$ XX Mn in 2021. The availability of technology, increasing healthcare spending, and government funding for research and development are some of the factors boosting the growth of the Nano therapy market in the region. Europe is expected to follow the Americas and bring in the second leading market share for Nano therapy throughout the forecast period. Europe is mainly driven by awareness and improvement in the nanotechnology sector.

Nano Therapy Market Recent Developments

• In 08 May 2019- Cisplatin cis-(diammine) dichloridoplatinum (II) (CDDP) is the first platinum based complex approved by the food and drug administration (FDA) of the United States (US). Cisplatin is the first line chemotherapeutic agent used alone or combined with radiations or other anti-cancer agents for a broad range of cancers such as lung, head and neck.

• In May 2019- A new study conducted by scientists from the Indian Institute of Technology, Bombay, have designed hybrid nanoparticles to treat cancer. These nanoparticles are made from gold and lipids. These nanoparticles respond to light and can be directed inside the body to release drugs to a targeted area, and are biocompatible, meaning they’re not toxic to a human body.

• In September 2019, researchers at Finland’s University of Helsinki, in partnership with the Åbo Akademi University and China’s Huazhong University of Science and Technology developed an anti-cancer nanomedicine useful for targeted cancer chemotherapy.

The objective of the report is to present a comprehensive analysis of the Global Nano Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Nano Therapy Market dynamics, structure by analyzing the market segments and project the Global Nano Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Nano Therapy Market make the report investor’s guide.

Global Nano Therapy Market Scope: Inquire before buying






Global Nano Therapy Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 176.77 Bn.




Forecast Period 2022 to 2029 CAGR:
8.6%
Market Size in 2029:
US $ 342.02 Bn.




 Segments Covered:
by Type
• Nanomaterial and Biological Device
• Nano Electronic Biosensor
• Molecular Nanotechnology
• Implantable Cardioverter-Defibrillators




by Application
• Cardiovascular Disease
• Cancer Therapy
• Diabetes Treatment
• Rheumatoid Arthritis






Global Nano Therapy Market, by Regions

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)

Global Nano Therapy Market Key Players

• Selecta Biosciences Inc.
• Cristal Therapeutics
• Sirnaomics Inc.
• Nanobiotix
• Luna
• CytImmune Science Inc.
• NanoBio Corporation
• Nanospectra Biosciences Inc.
• Nanoprobes Inc.
• NanoBioMagnetics.n.nu
• Smith and Nephew
• NanoMedia Solutions Inc.
• Nanosphere Inc.
• DIM
• Parvus Therapeutics
• Tarveda Therapeutics
• Pfizer Inc.
• Ablynx
• NANOVIRICIDES, INC.
• Arrowhead Pharmaceuticals, Inc.
• CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY
• Bio-Gate AG
• Merck & Co., Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Nano Therapy Market?
Ans: North America region helds the highest share in 2021.

2. What is the growth rate of Global Nano Therapy Market?
Ans: The Global Nano Therapy Market is growing at a CAGR of 8.6% during forecasting period 2022-2029.

3. What is scope of the Global Nano Therapy market report?
Ans: Global Nano Therapy Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Nano Therapy market?
Ans: The important key players in the Global Nano Therapy Market are – Selecta Biosciences Inc., Cristal Therapeutics, Sirnaomics Inc., Nanobiotix, Luna, CytImmune Science Inc., NanoBio Corporation, Nanospectra Biosciences Inc., Nanoprobes Inc., NanoBioMagnetics.n.nu, Smith and Nephew, and NanoMedia Solutions Inc.

5. What is the study period of this market?
Ans: The Global Nano Therapy Market is studied from 2021 to 2029. 




Global Nano Therapy Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Nano Therapy Market Size, by Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
4.8. Patent Registration

5. Supply Side and Demand Side Indicators
6. Global Nano Therapy Market Analysis and Forecast
6.1. Global Nano Therapy Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Nano Therapy Market Analysis and Forecast, By Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Nano Therapy Market Value Share Analysis, By Type
7.4. Global Nano Therapy Market Size (US$ Mn) Forecast, By Type
7.5. Global Nano Therapy Market Analysis, By Type
7.6. Global Nano Therapy Market Attractiveness Analysis, By Type

8. Global Nano Therapy Market Analysis and Forecast, By Application
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Nano Therapy Market Value Share Analysis, By Application
8.4. Global Nano Therapy Market Size (US$ Mn) Forecast, By Application
8.5. Global Nano Therapy Market Analysis, By Application
8.6. Global Nano Therapy Market Attractiveness Analysis, By Application

9. Global Nano Therapy Market Analysis, by Region
9.1. Global Nano Therapy Market Value Share Analysis, by Region
9.2. Global Nano Therapy Market Size (US$ Mn) Forecast, by Region
9.3. Global Nano Therapy Market Attractiveness Analysis, by Region

10. North America Nano Therapy Market Analysis
10.1. Key Findings
10.2. North America Nano Therapy Market Overview
10.3. North America Nano Therapy Market Value Share Analysis, By Type
10.4. North America Nano Therapy Market Forecast, By Type
10.4.1. Nanomaterial and Biological Device
10.4.2. Nano Electronic Biosensor
10.4.3. Molecular Nanotechnology
10.4.4. Implantable Cardioverter-Defibrillators
10.5. North America Nano Therapy Market Value Share Analysis, By Application
10.6. North America Nano Therapy Market Forecast, by Application
10.6.1. Cardiovascular Disease
10.6.2. Cancer Therapy
10.6.3. Diabetes Treatment
10.6.4. Rheumatoid Arthritis
10.7. North America Nano Therapy Market Value Share Analysis, by Country
10.8. North America Nano Therapy Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Nano Therapy Market Analysis, by Country
10.10. U.S. Nano Therapy Market Forecast, By Type
10.10.1. Nanomaterial and Biological Device
10.10.2. Nano Electronic Biosensor
10.10.3. Molecular Nanotechnology
10.10.4. Implantable Cardioverter-Defibrillators
10.11. U.S. Nano Therapy Market Forecast, By Application
10.11.1. Cardiovascular Disease
10.11.2. Cancer Therapy
10.11.3. Diabetes Treatment
10.11.4. Rheumatoid Arthritis
10.12. Canada Nano Therapy Market Forecast, By Type
10.12.1. Nanomaterial and Biological Device
10.12.2. Nano Electronic Biosensor
10.12.3. Molecular Nanotechnology
10.12.4. Implantable Cardioverter-Defibrillators
10.13. Canada Nano Therapy Market Forecast, By Application
10.13.1. Cardiovascular Disease
10.13.2. Cancer Therapy
10.13.3. Diabetes Treatment
10.13.4. Rheumatoid Arthritis
10.14. North America Nano Therapy Market Attractiveness Analysis
10.14.1. By Type
10.14.2. By Application
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Development

11. Europe Nano Therapy Market Analysis
11.1. Key Findings
11.2. Europe Nano Therapy Market Overview
11.3. Europe Nano Therapy Market Value Share Analysis, By Type
11.4. Europe Nano Therapy Market Forecast, By Type
11.4.1. Nanomaterial and Biological Device
11.4.2. Nano Electronic Biosensor
11.4.3. Molecular Nanotechnology
11.4.4. Implantable Cardioverter-Defibrillators
11.5. Europe Nano Therapy Market Value Share Analysis, By Application
11.6. Europe Nano Therapy Market Forecast, By Application
11.6.1. Cardiovascular Disease
11.6.2. Cancer Therapy
11.6.3. Diabetes Treatment
11.6.4. Rheumatoid Arthritis
11.7. Europe Nano Therapy Market Value Share Analysis, by Country
11.8. Europe Nano Therapy Market Forecast, by Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe Nano Therapy Market Analysis, by Country
11.10. Germany Nano Therapy Market Forecast, By Type
11.10.1. Nanomaterial and Biological Device
11.10.2. Nano Electronic Biosensor
11.10.3. Molecular Nanotechnology
11.10.4. Implantable Cardioverter-Defibrillators
11.11. Germany Nano Therapy Market Forecast, By Application
11.11.1. Cardiovascular Disease
11.11.2. Cancer Therapy
11.11.3. Diabetes Treatment
11.11.4. Rheumatoid Arthritis
11.12. U.K. Nano Therapy Market Forecast, By Type
11.12.1. Nanomaterial and Biological Device
11.12.2. Nano Electronic Biosensor
11.12.3. Molecular Nanotechnology
11.12.4. Implantable Cardioverter-Defibrillators
11.13. U.K. Nano Therapy Market Forecast, By Application
11.13.1. Cardiovascular Disease
11.13.2. Cancer Therapy
11.13.3. Diabetes Treatment
11.13.4. Rheumatoid Arthritis
11.14. France Nano Therapy Market Forecast, By Type
11.14.1. Nanomaterial and Biological Device
11.14.2. Nano Electronic Biosensor
11.14.3. Molecular Nanotechnology
11.14.4. Implantable Cardioverter-Defibrillators
11.15. France Nano Therapy Market Forecast, By Application
11.15.1. Cardiovascular Disease
11.15.2. Cancer Therapy
11.15.3. Diabetes Treatment
11.15.4. Rheumatoid Arthritis
11.16. Italy Nano Therapy Market Forecast, By Type
11.16.1. Nanomaterial and Biological Device
11.16.2. Nano Electronic Biosensor
11.16.3. Molecular Nanotechnology
11.16.4. Implantable Cardioverter-Defibrillators
11.17. Italy Nano Therapy Market Forecast, By Application
11.17.1. Cardiovascular Disease
11.17.2. Cancer Therapy
11.17.3. Diabetes Treatment
11.17.4. Rheumatoid Arthritis
11.18. Spain Nano Therapy Market Forecast, By Type
11.18.1. Nanomaterial and Biological Device
11.18.2. Nano Electronic Biosensor
11.18.3. Molecular Nanotechnology
11.18.4. Implantable Cardioverter-Defibrillators
11.19. Spain Nano Therapy Market Forecast, By Application
11.19.1. Cardiovascular Disease
11.19.2. Cancer Therapy
11.19.3. Diabetes Treatment
11.19.4. Rheumatoid Arthritis
11.20. Rest of Europe Nano Therapy Market Forecast, By Type
11.20.1. Nanomaterial and Biological Device
11.20.2. Nano Electronic Biosensor
11.20.3. Molecular Nanotechnology
11.20.4. Implantable Cardioverter-Defibrillators
11.21. Rest of Europe Nano Therapy Market Forecast, By Application
11.21.1. Cardiovascular Disease
11.21.2. Cancer Therapy
11.21.3. Diabetes Treatment
11.21.4. Rheumatoid Arthritis
11.22. Europe Nano Therapy Market Attractiveness Analysis
11.22.1. By Type
11.22.2. By Application
11.23. PEST Analysis
11.24. Key Trend
11.25. Key Development

12. Asia Pacific Nano Therapy Market Analysis
12.1. Key Findings
12.2. Asia Pacific Nano Therapy Market Overview
12.3. Asia Pacific Nano Therapy Market Value Share Analysis, By Type
12.4. Asia Pacific Nano Therapy Market Forecast, By Type
12.4.1. Nanomaterial and Biological Device
12.4.2. Nano Electronic Biosensor
12.4.3. Molecular Nanotechnology
12.4.4. Implantable Cardioverter-Defibrillators
12.5. Asia Pacific Nano Therapy Market Value Share Analysis, By Application
12.6. Asia Pacific Nano Therapy Market Forecast, By Application
12.6.1. Cardiovascular Disease
12.6.2. Cancer Therapy
12.6.3. Diabetes Treatment
12.6.4. Rheumatoid Arthritis
12.7. Asia Pacific Nano Therapy Market Value Share Analysis, by Country
12.8. Asia Pacific Nano Therapy Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Nano Therapy Market Analysis, by Country
12.10. China Nano Therapy Market Forecast, By Type
12.10.1. Nanomaterial and Biological Device
12.10.2. Nano Electronic Biosensor
12.10.3. Molecular Nanotechnology
12.10.4. Implantable Cardioverter-Defibrillators
12.11. China Nano Therapy Market Forecast, By Application
12.11.1. Cardiovascular Disease
12.11.2. Cancer Therapy
12.11.3. Diabetes Treatment
12.11.4. Rheumatoid Arthritis
12.12. India Nano Therapy Market Forecast, By Type
12.12.1. Nanomaterial and Biological Device
12.12.2. Nano Electronic Biosensor
12.12.3. Molecular Nanotechnology
12.12.4. Implantable Cardioverter-Defibrillators
12.13. India Nano Therapy Market Forecast, By Application
12.13.1. Cardiovascular Disease
12.13.2. Cancer Therapy
12.13.3. Diabetes Treatment
12.13.4. Rheumatoid Arthritis
12.14. Japan Nano Therapy Market Forecast, By Type
12.14.1. Nanomaterial and Biological Device
12.14.2. Nano Electronic Biosensor
12.14.3. Molecular Nanotechnology
12.14.4. Implantable Cardioverter-Defibrillators
12.15. Japan Nano Therapy Market Forecast, By Application
12.15.1. Cardiovascular Disease
12.15.2. Cancer Therapy
12.15.3. Diabetes Treatment
12.15.4. Rheumatoid Arthritis
12.16. ASEAN Nano Therapy Market Forecast, By Type
12.16.1. Nanomaterial and Biological Device
12.16.2. Nano Electronic Biosensor
12.16.3. Molecular Nanotechnology
12.16.4. Implantable Cardioverter-Defibrillators
12.17. ASEAN Nano Therapy Market Forecast, By Application
12.17.1. Cardiovascular Disease
12.17.2. Cancer Therapy
12.17.3. Diabetes Treatment
12.17.4. Rheumatoid Arthritis
12.18. Rest of Asia Pacific Nano Therapy Market Forecast, By Type
12.18.1. Nanomaterial and Biological Device
12.18.2. Nano Electronic Biosensor
12.18.3. Molecular Nanotechnology
12.18.4. Implantable Cardioverter-Defibrillators
12.19. Rest of Asia Pacific Nano Therapy Market Forecast, By Application
12.19.1. Cardiovascular Disease
12.19.2. Cancer Therapy
12.19.3. Diabetes Treatment
12.19.4. Rheumatoid Arthritis
12.20. Asia Pacific Nano Therapy Market Attractiveness Analysis
12.20.1. By Type
12.20.2. By Application
12.21. PEST Analysis
12.22. Key Trend
12.23. Key Development

13. Middle East & Africa Nano Therapy Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Nano Therapy Market Overview
13.3. Middle East & Africa Nano Therapy Market Value Share Analysis, By Type
13.4. Middle East & Africa Nano Therapy Market Forecast, By Type
13.4.1. Nanomaterial and Biological Device
13.4.2. Nano Electronic Biosensor
13.4.3. Molecular Nanotechnology
13.4.4. Implantable Cardioverter-Defibrillators
13.5. Middle East & Africa Nano Therapy Market Value Share Analysis, By Application
13.6. Middle East & Africa Nano Therapy Market Forecast, By Application
13.6.1. Cardiovascular Disease
13.6.2. Cancer Therapy
13.6.3. Diabetes Treatment
13.6.4. Rheumatoid Arthritis
13.7. Middle East & Africa Nano Therapy Market Value Share Analysis, by Country
13.8. Middle East & Africa Nano Therapy Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Nano Therapy Market Analysis, by Country
13.10. GCC Nano Therapy Market Forecast, By Type
13.10.1. Nanomaterial and Biological Device
13.10.2. Nano Electronic Biosensor
13.10.3. Molecular Nanotechnology
13.10.4. Implantable Cardioverter-Defibrillators
13.11. GCC Nano Therapy Market Forecast, By Application
13.11.1. Cardiovascular Disease
13.11.2. Cancer Therapy
13.11.3. Diabetes Treatment
13.11.4. Rheumatoid Arthritis
13.12. South Africa Nano Therapy Market Forecast, By Type
13.12.1. Nanomaterial and Biological Device
13.12.2. Nano Electronic Biosensor
13.12.3. Molecular Nanotechnology
13.12.4. Implantable Cardioverter-Defibrillators
13.13. South Africa Nano Therapy Market Forecast, By Application
13.13.1. Cardiovascular Disease
13.13.2. Cancer Therapy
13.13.3. Diabetes Treatment
13.13.4. Rheumatoid Arthritis
13.14. Rest of Middle East & Africa Nano Therapy Market Forecast, By Type
13.14.1. Nanomaterial and Biological Device
13.14.2. Nano Electronic Biosensor
13.14.3. Molecular Nanotechnology
13.14.4. Implantable Cardioverter-Defibrillators
13.15. Rest of Middle East & Africa Nano Therapy Market Forecast, By Application
13.15.1. Cardiovascular Disease
13.15.2. Cancer Therapy
13.15.3. Diabetes Treatment
13.15.4. Rheumatoid Arthritis
13.16. Middle East & Africa Nano Therapy Market Attractiveness Analysis
13.16.1. By Type
13.16.2. By Application
13.17. PEST Analysis
13.18. Key Trend
13.19. Key Development

14. South America Nano Therapy Market Analysis
14.1. Key Findings
14.2. South America Nano Therapy Market Overview
14.3. South America Nano Therapy Market Value Share Analysis, By Type
14.4. South America Nano Therapy Market Forecast, By Type
14.4.1. Nanomaterial and Biological Device
14.4.2. Nano Electronic Biosensor
14.4.3. Molecular Nanotechnology
14.4.4. Implantable Cardioverter-Defibrillators
14.5. South America Nano Therapy Market Value Share Analysis, By Application
14.6. South America Nano Therapy Market Forecast, By Application
14.6.1. Cardiovascular Disease
14.6.2. Cancer Therapy
14.6.3. Diabetes Treatment
14.6.4. Rheumatoid Arthritis
14.7. South America Nano Therapy Market Value Share Analysis, by Country
14.8. South America Nano Therapy Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. Brazil Nano Therapy Market Forecast, By Type
14.9.1. Nanomaterial and Biological Device
14.9.2. Nano Electronic Biosensor
14.9.3. Molecular Nanotechnology
14.9.4. Implantable Cardioverter-Defibrillators
14.10. Brazil Nano Therapy Market Forecast, By Application
14.10.1. Cardiovascular Disease
14.10.2. Cancer Therapy
14.10.3. Diabetes Treatment
14.10.4. Rheumatoid Arthritis
14.11. Mexico Nano Therapy Market Forecast, By Type
14.11.1. Nanomaterial and Biological Device
14.11.2. Nano Electronic Biosensor
14.11.3. Molecular Nanotechnology
14.11.4. Implantable Cardioverter-Defibrillators
14.12. Mexico Nano Therapy Market Forecast, By Application
14.12.1. Cardiovascular Disease
14.12.2. Cancer Therapy
14.12.3. Diabetes Treatment
14.12.4. Rheumatoid Arthritis
14.13. Rest of South America Nano Therapy Market Forecast, By Type
14.13.1. Nanomaterial and Biological Device
14.13.2. Nano Electronic Biosensor
14.13.3. Molecular Nanotechnology
14.13.4. Implantable Cardioverter-Defibrillators
14.14. Rest of South America Nano Therapy Market Forecast, By Application
14.14.1. Cardiovascular Disease
14.14.2. Cancer Therapy
14.14.3. Diabetes Treatment
14.14.4. Rheumatoid Arthritis
14.15. South America Nano Therapy Market Attractiveness Analysis
14.15.1. By Type
14.15.2. By Application
14.16. PEST Analysis
14.17. Key Trend
14.18. Key Development

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.4. M&A by Regions, Investment and Applications
15.2.5. M&A Key Players, Forward Integration and Backward Integration
15.3. Company Profiles: Key Players
15.3.1. Selecta Biosciences Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Company Footprint
15.3.2. Cristal Therapeutics
15.3.3. Sirnaomics Inc.
15.3.4. Nanobiotix
15.3.5. Luna
15.3.6. CytImmune Science Inc.
15.3.7. NanoBio Corporation
15.3.8. Nanospectra Biosciences Inc.
15.3.9. Nanoprobes Inc.
15.3.10. NanoBioMagnetics.n.nu
15.3.11. Smith and Nephew
15.3.12. NanoMedia Solutions Inc.
15.3.13. Nanosphere Inc.
15.3.14. DIM
15.3.15. Parvus Therapeutics
15.3.16. Tarveda Therapeutics
15.3.17. Pfizer Inc. 
15.3.18. Ablynx
15.3.19. NANOVIRICIDES, INC.
15.3.20. Arrowhead Pharmaceuticals, Inc.
15.3.21. CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY
15.3.22. Bio-Gate AG
15.3.23. Merck & Co., Inc.

16. Primary Key Insights
  • INQUIRE BEFORE BUYING